STOCK TITAN

Petmed Express, Inc. - PETS STOCK NEWS

Welcome to our dedicated news page for Petmed Express (Ticker: PETS), a resource for investors and traders seeking the latest updates and insights on Petmed Express.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Petmed Express's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Petmed Express's position in the market.

Rhea-AI Summary
PetMed Express, Inc. (PETS) announced its fiscal 2024 third quarter financial results, reporting a revenue of $65.3 million, an 11% increase from the previous year. The company highlighted the growth in AutoShip & Save and PetPlus Membership, accounting for 52% of total revenue. PetMeds also emphasized its strong balance sheet with $49.4 million in cash. The completion of a financial restatement was mentioned, with the company now current in all SEC filings. The restatement corrected accounting treatment for prior period sales taxes, resulting in adjustments to financial statements for fiscal years 2023, 2022, and 2021, as well as interim financial statements for 2023 and 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
-
Rhea-AI Summary
PetMed Express, Inc. (NASDAQ: PETS) partners with Hill’s Pet Nutrition to offer Science Diet products through petmeds.com. The company is giving away a year’s worth of Hill’s Science Diet to three winners along with a $1,000 credit to a pet shelter of their choice. The promotion runs from February 16 to March 15, 2024, with no purchase necessary. PetMeds® aims to support responsible pet ownership and help animal shelters facing capacity crises.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.07%
Tags
none
-
Rhea-AI Summary
PetMed Express, Inc. (PETS) received a notice from Nasdaq due to a delayed filing of Form 10-Q, leading to non-compliance with Nasdaq Listing Rule 5250(c)(1). The company must submit a plan to regain compliance within 60 days. The delay was caused by a financial statement restatement, detailed in a recent Form 8-K filing. PetMeds® is actively working to complete the restatement and file the Form 10-Q promptly.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
none
Rhea-AI Summary
PetMed Express, Inc. announces restatement of financial statements due to accounting errors. Preliminary financial results for Q3 2023 show an 11% increase in net sales. Gross profit expected to be $17.9 million, up from $15.2 million. Cash and equivalents at $49.4 million. Restatement to affect multiple periods, decreasing general and administrative expense for fiscal year 2023 by $6-8 million and increasing net income. No expected impact on fiscal year 2024 revenue, cost of goods sold, or cash.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
-
Rhea-AI Summary
PetMed Express, Inc. (Nasdaq: PETS) will hold a conference call on February 8, 2024, to discuss its financial results for the fiscal third quarter ended December 31, 2023. The call will be hosted by PetMeds’ management and will include a question and answer period. The company's financial results will be issued in a press release prior to the call. The call will be accessible via U.S. and international dial-in numbers, as well as a webcast link. A telephonic replay will also be available after the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
-
Rhea-AI Summary
PetMed Express, Inc. (NASDAQ: PETS) appoints Leslie C. G. Campbell as Chairman of the Board effective January 5, 2024, as part of the company's ongoing Board composition and succession planning. Ms. Campbell has served on PetMeds' Board since 2018 and will continue to serve as Chair of the Compensation Committee and a member of the Audit and Corporate Governance and Nominating Committees. As Chairman, Ms. Campbell succeeds Dr. Gian Fulgoni, who will remain a member of the Board and its various committees and continue to chair the Board's Corporate Governance and Nominating Committee.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.9%
Tags
none
Rhea-AI Summary
PetMed Express, Inc. (PETS) revealed the results of a new survey conducted by OnePoll that show just how much pet parents miss their beloved friends when they are at work. Four in 10 pet parents said they would take a lower salary to work from home in order to be closer to their pets. The PetMeds® survey found that pet parents begin to miss their pets on average just 37 minutes after being apart.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.6%
Tags
none
-
Rhea-AI Summary
PetMed Express, Inc. (PetMeds®, NASDAQ: PETS) announces the creation of its Veterinarian Advisory Board led by Dr. Lori Teller, aiming to improve outcomes for pets and pet parents. The board will consist of expert voices in the veterinary space, offering insights into pet care and wellbeing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.76%
Tags
management
-
Rhea-AI Summary
PetMed Express, Inc. (NASDAQ: PETS) announced its financial results for Q2 2023. Net sales were $71.0 million, up 9% YoY. New customers increased by 25% YoY. Net loss was $70 thousand compared to net income of $2.6 million in Q2 2022. Adjusted EBITDA was $3.2 million, a decrease of 55% YoY.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-24.95%
Tags
Rhea-AI Summary
PetMed Express, Inc. to hold conference call to discuss financial results for Q2 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.37%
Tags
Petmed Express, Inc.

Nasdaq:PETS

PETS Rankings

PETS Stock Data

87.97M
18.12M
4.42%
74.96%
23.17%
Pharmacies and Drug Stores
Retail Trade
Link
US
Delray Beach

About PETS

petmeds® is america's largest pet pharmacy, a publicly traded company (nasdaq: pets). we deliver prescription and non-prescription pet meds along with health and nutritional supplements for dogs, cats and horses at substantial savings directly to you. we serve millions of satisfied customers nationwide from one location.